Critical role of lipid rafts in CD154-mediated T cell signaling

European Journal of Immunology

Volumn 40, Issue 3, 2010, Pages 770-779

  El Fakhry, Youssef ^a   Alturaihi, Haydar ^a   Diallo, Djibril ^a   Merhi, Yehye ^b   Mourad, Walid ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

CD154; Lipid rafts; Signaling; T lymphocytes

Indexed keywords

CD40 LIGAND; CHELERYTHRINE; CYTOKINE; INTERLEUKIN 2; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NYSTATIN; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; SUPERANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LIPID RAFT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

EID: 77749285670     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939646     Document Type: Article

References (51)

1. Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M. et al., Molecular and biological characterization of a murine ligand for CD40. Nature 1992. 357: 80-82.
2. + T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med. 1992. 175: 1091-1101.
3. Graf, D., Korthauer, U., Mages, H. W., Senger, G. and Kroczek, R. A., Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol. 1992. 22: 3191-3194.
4. Henn, V., Slupsky, J. R., Grafe, M., Anagnostopoulos, I., Forster, R., Muller-Berghaus, G. and Kroczek, R. A., CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998. 391: 591-594.
5. Grammer, A. C. and Lipsky, P. E., CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. Adv. Immunol. 2000. 76: 61-178.
6. Andre, P., Prasad, K. S., Denis, C. V., He, M., Papalia, J. M., Hynes, R. O., Phillips, D. R. and Wagner, D. D., CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat. Med. 2002. 8: 247-252.
7. Chakrabarti, S., Varghese, S., Vitseva, O., Tanriverdi, K. and Freedman, J. E., CD40 ligand influences platelet release of reactive oxygen intermediates. Arterioscler. Thromb. Vasc. Biol. 2005. 25: 2428-2434.
8. Pietravalle, F., Lecoanet-Henchoz, S., Blasey, H., Aubry, J. P., Elson, G., Edgerton, M. D., Bonnefoy, J. Y. and Gauchat, J. F., Human native soluble CD40L is a biologically active trimer, processed inside microsomes. J. Biol. Chem. 1996. 271: 5965-5967.
9. Jin, Y., Nonoyama, S., Morio, T., Imai, K., Ochs, H. D. and Mizutani, S., Characterization of soluble CD40 ligand released from human activated platelets. J. Med. Dent. Sci. 2001. 48: 23-27.
10. Leveille, C., Bouillon, M., Guo, W., Bolduc, J., Sharif-Askari, E., El-Fakhry, Y., Reyes-Moreno, C. et al., CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling. J. Biol. Chem. 2007. 282: 5143-5151.
11. Zirlik, A., Maier, C., Gerdes, N., MacFarlane, L., Soosairajah, J., Bavendiek, U., Ahrens, I. et al., CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 2007. 115: 1571-1580.
12. Schonbeck, U. and Libby, P., The CD40/CD154 receptor/ligand dyad. Cell. Mol. Life Sci. 2001. 58: 4-43.
13. Howard, L. M. and Miller, S. D., Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease. Autoimmunity 2004. 37: 411-418.
14. Toubi, E. and Shoenfeld, Y., The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 2004. 37: 457-464.
15. Danese, S., Sans, M. and Fiocchi, C., The CD40/CD40L costimulatory pathway in inflammatory bowel disease. Gut 2004. 53: 1035-1043.
16. Allen, R. C., Armitage, R. J., Conley, M. E., Rosenblatt, H., Jenkins, N. A., Copeland, N. G., Bedell, M. A. et al., CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993. 259: 990-993.
17. Boisvert, J., Edmondson, S. and Krummel, M. F., Immunological synapse formation licenses CD40-CD40L accumulations at T-APC contact sites. J. Immunol. 2004. 173: 3647-3652.
18. Brenner, B., Koppenhoefer, U., Lepple-Wienhues, A., Grassme, H., Muller, C., Speer, C. P., Lang, F. and Gulbins, E., The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activation. Biochem. Biophys. Res. Commun. 1997. 239: 11-17.
19. Brenner, B., Koppenhoefer, U., Grassme, H., Kun, J., Lang, F. and Gulbins, E., Evidence for a novel function of the CD40 ligand as a signalling molecule in T-lymphocytes. FEBS Lett. 1997. 417: 301-306.
20. Koppenhoefer, U., Brenner, B., Lang, F. and Gulbins, E., The CD40-ligand stimulates T-lymphocytes via the neutral sphingomyelinase: a novel function of the CD40-ligand as signalling molecule. FEBS Lett. 1997. 414: 444-448.
21. Blotta, M. H., Marshall, J. D., DeKruyff, R. H. and Umetsu, D. T., Crosslinking of the CD40 ligand on human CD4+T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis. J. Immunol. 1996. 156: 3133-3140.
22. Blair, P. J., Riley, J. L., Harlan, D. M., Abe, R., Tadaki, D. K., Hoffmann, S. C., White, L. et al., CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J. Exp. Med. 2000. 191: 651-660.
23. + T lymphocytes. J. Immunol. 1994. 152: 1523-1531.
24. Suzuki, I. and Fink, P. J., Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 1998. 187: 123-128.
25. Eissner, G., Kirchner, S., Lindner, H., Kolch, W., Janosch, P., Grell, M., Scheurich, P. et al., Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J. Immunol. 2000. 164: 6193-6198.
26. Kirchner, S., Holler, E., Haffner, S., Andreesen, R. and Eissner, G., Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes. Cytokine 2004. 28: 67-74.
27. Sun, M., Ames, K. T., Suzuki, I. and Fink, P. J., The cytoplasmic domain of Fas ligand costimulates TCR signals. J. Immunol. 2006. 177: 1481-1491.
28. Vudattu, N. K., Holler, E., Ewing, P., Schulz, U., Haffner, S., Burger, V., Kirchner, S. et al., Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+and CD8+ T cells against human microvascular endothelial cells. Immunology 2005. 115: 536-543.
29. Tani-ichi, S., Maruyama, K., Kondo, N., Nagafuku, M., Kabayama, K., Inokuchi, J., Shimada, Y. et al., Structure and function of lipid rafts in human activated T cells. Int. Immunol. 2005. 17: 749-758.
30. Bi, K. and Altman, A., Membrane lipid microdomains and the role of PKCtheta in T cell activation. Semin. Immunol. 2001. 13: 139-146.
31. Stuber, E., Strober, W. and Neurath, M., Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 1996. 183: 693-698.
32. Hughes-Fulford, M., Sugano, E., Schopper, T., Li, C. F., Boonyaratanakornkit, J. B. and Cogoli, A., Early immune response and regulation of IL-2 receptor subunits. Cell. Signal. 2005. 17: 1111-1124.
33. Matsuda, S., Moriguchi, T., Koyasu, S. and Nishida, E., T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J. Biol. Chem. 1998. 273: 12378-12382.
34. Yu, T. C., Liu, Y., Tan, Y., Jiang, Y., Zheng, X. and Xu, X., Shock waves increase T-cell proliferation or IL-2 expression by activating p38 MAP kinase. Acta Biochim. Biophys. Sin. (Shanghai) 2004. 36: 741-748.
35. Yellin, M. J., Lee, J. J., Chess, L. and Lederman, S., A human CD4- T cell leukemia subclone with contact-dependent helper function. J. Immunol. 1991. 147: 3389-3395.
36. Reyes-Moreno, C., Sharif-Askari, E., Girouard, J., Leveille, C., Jundi, M., Akoum, A., Lapointe, R. et al., Requirement of oxidation-dependent CD40 homodimers for CD154/CD40 bidirectional signaling. J. Biol. Chem. 2007. 282: 19473-19480.
37. Burkly, L. C., CD40 pathway blockade as an approach to immunotherapy. Adv. Exp. Med. Biol. 2001. 489: 135-152.
38. Poudrier, J., van Essen, D., Morales-Alcelay, S., Leanderson, T., Bergthorsdottir, S. and Gray, D., CD40 ligand signals optimize T helper cell cytokine production: role in Th2 development and induction of germinal centers. Eur. J. Immunol. 1998. 28: 3371-3383.
39. van Essen, D., Kikutani, H. and Gray, D., CD40 ligand-transduced costimulation of T cells in the development of helper function. Nature 1995. 378: 620-623.
40. Watts, T. H., in Lymphocyte Signaling: Mechanisms, Subversion and Manipulation, Wiley, New York 1997, pp. 141-161.
41. Montixi, C., Langlet, C., Bernard, A. M., Thimonier, J., Dubois, C.,Wurbel, M. A., Chauvin, J. P., et al., Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J. 1998. 17: 5334-5348.
42. Langlet, C., Bernard, A. M., Drevot, P. and He, H. T., Membrane rafts and signaling by the multichain immune recognition receptors. Curr. Opin. Immunol. 2000. 12: 250-255.
43. Grassme, H., Bock, J., Kun, J. and Gulbins, E., Clustering of CD40 ligand is required to form a functional contact with CD40. J. Biol. Chem. 2002. 277: 30289-30299.
44. Rub, A., Dey, R., Jadhav, M., Kamat, R., Chakkaramakkil, S., Majumdar, S., Mukhopadhyaya, R. and Saha, B., Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat. Immunol. 2009. 10: 273-280.
45. Unruh, T. L., Li, H., Mutch, C. M., Shariat, N., Grigoriou, L., Sanyal, R., Brown, C. B. and Deans, J. P., Cholesterol depletion inhibits src family kinase-dependent calcium mobilization and apoptosis induced by rituximab crosslinking. Immunology 2005. 116: 223-232.
46. Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D. et al., A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994. 372: 739-746.
47. Yamauchi, J., Nagao, M., Kaziro, Y. and Itoh, H., Activation of p38 mitogen-activated protein kinase by signaling through G protein-coupled receptors involvement of Gbetagamma and Galphaq/11 subunits. J. Biol. Chem. 1997. 272: 27771-27777.
48. Mikolajczak, S. A., Ma, B. Y., Yoshida, T., Yoshida, R., Kelvin, D. J. and Ochi, A., The Modulation of CD40 ligand signaling by transmembrane CD28 splice variant in human T cells. J. Exp. Med. 2004. 199: 1025-1031.
49. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. and Pease, L. R., Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989. 77: 51-59.
50. Brown, D. A. and Rose, J. K., Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992. 68: 533-544.
51. El Fakhry, Y., Bouillon, M., Leveille, C., Brunet, A., Khalil, H., Thibodeau, J. and Mourad, W., Delineation of the HLA-DR region and the residues involved in the association with the cytoskeleton. J. Biol. Chem. 2004 279: 18472-18480.